Codevelopment of new antiretrovirals in very treatment-experienced HIV-infected individuals.
Youle
Mike
M
Cohen
Cal
C
Katlama
Christine
C
Kuritzkes
Dan
D
Walmsley
Sharon
S
D044966:Anti-Retroviral Agents / Q000008:administration & dosage*; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination; D015507:Drugs, Investigational / Q000008:administration & dosage*; D000077560:Enfuvirtide; D015700:HIV Envelope Protein gp41 / Q000627:therapeutic use; D023581:HIV Fusion Inhibitors / Q000627:therapeutic use; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D010446:Peptide Fragments / Q000627:therapeutic use; D011725:Pyridines / Q000627:therapeutic use; D011753:Pyrones / Q000627:therapeutic use; D013449:Sulfonamides
D044966:Anti-Retroviral Agents; D015507:Drugs, Investigational; D015700:HIV Envelope Protein gp41; D023581:HIV Fusion Inhibitors; D010446:Peptide Fragments; D011725:Pyridines; D011753:Pyrones; D013449:Sulfonamides; D000077560:Enfuvirtide; C107201:tipranavir